Skip to main content
Top
Published in: BMC Infectious Diseases 1/2018

Open Access 01-12-2018 | Research article

A nested case–control study of predictors for tuberculosis recurrence in a large UK Centre

Authors: Andrew Rosser, Matthew Richardson, Martin J. Wiselka, Robert C. Free, Gerrit Woltmann, Galina V. Mukamolova, Manish Pareek

Published in: BMC Infectious Diseases | Issue 1/2018

Login to get access

Abstract

Background

Tuberculosis (TB) recurrence represents a challenge to control programs. In low incidence countries, the prevailing risk factors leading to recurrence are poorly characterised.

Methods

We conducted a nested case–control study using the Leicester TB service TBIT database. Cases were identified from database notifications between 1994 and 2014. Controls had one episode and were matched to cases on a ratio of two to one by the date of notification. Multiple imputation was used to account for missing data. Multivariate conditional logistic regression analysis was employed to identify clinical, sociodemographic and TB specific risk factors for recurrence.

Results

From a cohort of 4628 patients, 82 TB recurrences occurred (1.8%). Nineteen of 82 patients had paired isolates with MIRU-VNTR strain type profiles available, of which 84% were relapses and 16% reinfections. On multivariate analysis, smoking (OR 3.8; p = 0.04), grade 3/4 adverse drug reactions (OR 5.6; p = 0.02), ethnicity ‘Indian subcontinent’ (OR 8.5; p = <0.01), ethnicity ‘other’ (OR 31.2; p = 0.01) and receipt of immunosuppressants (OR 6.8; p = <0.01) were independent predictors of TB recurrence.

Conclusions

Within this UK setting, the rate of TB recurrence was low, predominantly due to relapse. The identification of an elevated recurrence risk amongst the ethnic group contributing most cases to the national TB burden presents an opportunity to improve individual and population health.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lambert ML, Hasker E, Van Deun A, Roberfroid D, Boelaert M, Van der Stuyft P. Recurrence in tuberculosis: relapse or reinfection? Lancet Infect Dis. 2003;3(5):282–7.CrossRefPubMed Lambert ML, Hasker E, Van Deun A, Roberfroid D, Boelaert M, Van der Stuyft P. Recurrence in tuberculosis: relapse or reinfection? Lancet Infect Dis. 2003;3(5):282–7.CrossRefPubMed
2.
go back to reference Sonnenberg P, Murray J, Glynn JR, Shearer S, Kambashi B, Godfrey-Faussett P. HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet. 2001;358(9294):1687–93.CrossRefPubMed Sonnenberg P, Murray J, Glynn JR, Shearer S, Kambashi B, Godfrey-Faussett P. HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet. 2001;358(9294):1687–93.CrossRefPubMed
3.
go back to reference Millet JP, Shaw E, Orcau A, Casals M, Miro JM, Cayla JA. Tuberculosis recurrence after completion treatment in a European city: reinfection or relapse? PLoS One. 2013;8(6):e64898.CrossRefPubMedPubMedCentral Millet JP, Shaw E, Orcau A, Casals M, Miro JM, Cayla JA. Tuberculosis recurrence after completion treatment in a European city: reinfection or relapse? PLoS One. 2013;8(6):e64898.CrossRefPubMedPubMedCentral
4.
go back to reference Millet JP, Orcau A, de Olalla PG, Casals M, Rius C, Cayla JA. Tuberculosis recurrence and its associated risk factors among successfully treated patients. J Epidemiol Community Health. 2009;63(10):799–804.CrossRefPubMed Millet JP, Orcau A, de Olalla PG, Casals M, Rius C, Cayla JA. Tuberculosis recurrence and its associated risk factors among successfully treated patients. J Epidemiol Community Health. 2009;63(10):799–804.CrossRefPubMed
5.
go back to reference Bang D, Andersen AB, Thomsen VO, Lillebaek T. Recurrent tuberculosis in Denmark: relapse vs. re-infection. Int J Tuberc Lung Dis. 2010;14(4):447–53.PubMed Bang D, Andersen AB, Thomsen VO, Lillebaek T. Recurrent tuberculosis in Denmark: relapse vs. re-infection. Int J Tuberc Lung Dis. 2010;14(4):447–53.PubMed
6.
go back to reference Guerra-Assuncao JA, Houben RM, Crampin AC, Mzembe T, Mallard K, Coll F, Khan P, Banda L, Chiwaya A, Pereira RP, et al. Recurrence due to relapse or reinfection with mycobacterium tuberculosis: a whole-genome sequencing approach in a large, population-based cohort with a high HIV infection prevalence and active follow-up. J Infect Dis. 2015;211(7):1154–63.CrossRefPubMed Guerra-Assuncao JA, Houben RM, Crampin AC, Mzembe T, Mallard K, Coll F, Khan P, Banda L, Chiwaya A, Pereira RP, et al. Recurrence due to relapse or reinfection with mycobacterium tuberculosis: a whole-genome sequencing approach in a large, population-based cohort with a high HIV infection prevalence and active follow-up. J Infect Dis. 2015;211(7):1154–63.CrossRefPubMed
7.
go back to reference Wang JY, Lee LN, Lai HC, Hsu HL, Liaw YS, Hsueh PR, Yang PC. Prediction of the tuberculosis reinfection proportion from the local incidence. J Infect Dis. 2007;196(2):281–8.CrossRefPubMed Wang JY, Lee LN, Lai HC, Hsu HL, Liaw YS, Hsueh PR, Yang PC. Prediction of the tuberculosis reinfection proportion from the local incidence. J Infect Dis. 2007;196(2):281–8.CrossRefPubMed
8.
go back to reference Narayanan S, Swaminathan S, Supply P, Shanmugam S, Narendran G, Hari L, Ramachandran R, Locht C, Jawahar MS, Narayanan PR. Impact of HIV infection on the recurrence of tuberculosis in South India. J Infect Dis. 2010;201(5):691–703.CrossRefPubMed Narayanan S, Swaminathan S, Supply P, Shanmugam S, Narendran G, Hari L, Ramachandran R, Locht C, Jawahar MS, Narayanan PR. Impact of HIV infection on the recurrence of tuberculosis in South India. J Infect Dis. 2010;201(5):691–703.CrossRefPubMed
9.
go back to reference Yen YF, Yen MY, Lin YS, Lin YP, Shih HC, Li LH, Chou P, Deng CY. Smoking increases risk of recurrence after successful anti-tuberculosis treatment: a population-based study. Int J Tuberc Lung Dis. 2014;18(4):492–8.CrossRefPubMed Yen YF, Yen MY, Lin YS, Lin YP, Shih HC, Li LH, Chou P, Deng CY. Smoking increases risk of recurrence after successful anti-tuberculosis treatment: a population-based study. Int J Tuberc Lung Dis. 2014;18(4):492–8.CrossRefPubMed
10.
go back to reference Khan A, Sterling TR, Reves R, Vernon A, Horsburgh CR. Lack of weight gain and relapse risk in a large tuberculosis treatment trial. Am J Respir Crit Care Med. 2006;174(3):344–8.CrossRefPubMed Khan A, Sterling TR, Reves R, Vernon A, Horsburgh CR. Lack of weight gain and relapse risk in a large tuberculosis treatment trial. Am J Respir Crit Care Med. 2006;174(3):344–8.CrossRefPubMed
11.
go back to reference Goswami A, Chakraborty U, Mahapatra T, Mahapatra S, Mukherjee T, Das S, Das A, Dey SK, Ray S, Battacharya B, et al. Correlates of treatment outcomes and drug REsistance among pulmonary tuberculosis Patiietns attending tertiary care hospitals of Kolkata, India. PLoS One. 2014;9(10):e109563.CrossRefPubMedPubMedCentral Goswami A, Chakraborty U, Mahapatra T, Mahapatra S, Mukherjee T, Das S, Das A, Dey SK, Ray S, Battacharya B, et al. Correlates of treatment outcomes and drug REsistance among pulmonary tuberculosis Patiietns attending tertiary care hospitals of Kolkata, India. PLoS One. 2014;9(10):e109563.CrossRefPubMedPubMedCentral
12.
go back to reference Schiroli C, Carugati M, Zanini F, Bandera A, Di Nardo SS, Monge E, Morosi M, Gori A, Matteelli A, Codecasa L, et al. Exogenous reinfection of tuberculosis in a low-burden area. Infection. 2015;43(6):647–53.CrossRefPubMed Schiroli C, Carugati M, Zanini F, Bandera A, Di Nardo SS, Monge E, Morosi M, Gori A, Matteelli A, Codecasa L, et al. Exogenous reinfection of tuberculosis in a low-burden area. Infection. 2015;43(6):647–53.CrossRefPubMed
14.
go back to reference Panjabi R, Comstock GW, Golub JE. Recurrent tuberculosis and its risk factors: adequately treated patients are still at high risk. Int J Tuberc Lung Dis. 2007;11(8):828–37.PubMed Panjabi R, Comstock GW, Golub JE. Recurrent tuberculosis and its risk factors: adequately treated patients are still at high risk. Int J Tuberc Lung Dis. 2007;11(8):828–37.PubMed
15.
go back to reference Cox H, Kebede Y, Allamuratova S, Ismailov G, Davletmuratova Z, Byrnes G, Stone C, Niemann S, Rusch-Gerdes S, Blok L, et al. Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance. PLoS Med. 2006;3(10):e384.CrossRefPubMedPubMedCentral Cox H, Kebede Y, Allamuratova S, Ismailov G, Davletmuratova Z, Byrnes G, Stone C, Niemann S, Rusch-Gerdes S, Blok L, et al. Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance. PLoS Med. 2006;3(10):e384.CrossRefPubMedPubMedCentral
16.
go back to reference Pascopella L, Deriemer K, Watt JP, Flood JM. When tuberculosis comes back: who develops recurrent tuberculosis in california? PLoS One. 2011;6(11):e26541.CrossRefPubMedPubMedCentral Pascopella L, Deriemer K, Watt JP, Flood JM. When tuberculosis comes back: who develops recurrent tuberculosis in california? PLoS One. 2011;6(11):e26541.CrossRefPubMedPubMedCentral
17.
go back to reference Luzze H, Johnson DF, Dickman K, Mayanja-Kizza H, Okwera A, Eisenach K, Cave MD, Whalen CC, Johnson JL, Boom WH, et al. Relapse more common than reinfection in recurrent tuberculosis 1–2 years post treatment in urban Uganda. Int J Tuberc Lung Dis. 2013;17(3):361–7.CrossRefPubMed Luzze H, Johnson DF, Dickman K, Mayanja-Kizza H, Okwera A, Eisenach K, Cave MD, Whalen CC, Johnson JL, Boom WH, et al. Relapse more common than reinfection in recurrent tuberculosis 1–2 years post treatment in urban Uganda. Int J Tuberc Lung Dis. 2013;17(3):361–7.CrossRefPubMed
18.
go back to reference Crofts JP, Andrews NJ, Barker RD, Delpech V, Abubakar I. Risk factors for recurrent tuberculosis in England and Wales, 1998–2005. Thorax. 2010;65(4):310–4.CrossRefPubMed Crofts JP, Andrews NJ, Barker RD, Delpech V, Abubakar I. Risk factors for recurrent tuberculosis in England and Wales, 1998–2005. Thorax. 2010;65(4):310–4.CrossRefPubMed
19.
go back to reference Chang KC, Leung CC, Yew WW, Ho SC, Tam CM. A nested case–control study on treatment-related risk factors for early relapse of tuberculosis. Am J Respir Crit Care Med. 2004;170(10):1124–30.CrossRefPubMed Chang KC, Leung CC, Yew WW, Ho SC, Tam CM. A nested case–control study on treatment-related risk factors for early relapse of tuberculosis. Am J Respir Crit Care Med. 2004;170(10):1124–30.CrossRefPubMed
20.
go back to reference Office for National Statistics. Population estimates for UK, England and Wales, Scotland and Northern Ireland, Mid-2014. London: ONS; 2015. Office for National Statistics. Population estimates for UK, England and Wales, Scotland and Northern Ireland, Mid-2014. London: ONS; 2015.
21.
go back to reference Tuberculosis in the east midlands: annual review (2015 data). In. London: Public Health England: East Midlands; 2016. Tuberculosis in the east midlands: annual review (2015 data). In. London: Public Health England: East Midlands; 2016.
22.
go back to reference NIfHaC E, editor. Tuberculosis - NICE Guideline [NG33]. London: NICE; 2016. NIfHaC E, editor. Tuberculosis - NICE Guideline [NG33]. London: NICE; 2016.
23.
go back to reference Definitions and reporting framework for tuberculosis – 2013 revision (updated December 2014): World Health Organisation; 2014. Definitions and reporting framework for tuberculosis – 2013 revision (updated December 2014): World Health Organisation; 2014.
24.
go back to reference Office for National Statistics. Ethnic group statistics: a guide for the collection and classification of ethnicity data. London: ONS; 2009. Office for National Statistics. Ethnic group statistics: a guide for the collection and classification of ethnicity data. London: ONS; 2009.
25.
go back to reference Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rusch-Gerdes S, Willery E, Savine E, de Haas P, van Deutekom H, Roring S, et al. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of mycobacterium tuberculosis. J Clin Microbiol. 2006;44(12):4498–510.CrossRefPubMedPubMedCentral Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rusch-Gerdes S, Willery E, Savine E, de Haas P, van Deutekom H, Roring S, et al. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of mycobacterium tuberculosis. J Clin Microbiol. 2006;44(12):4498–510.CrossRefPubMedPubMedCentral
26.
go back to reference Dobler CC, Crawford AB, Jelfs PJ, Gilbert GL, Marks GB. Recurrence of tuberculosis in a low-incidence setting. Eur Respir J. 2009;33(1):160–7.CrossRefPubMed Dobler CC, Crawford AB, Jelfs PJ, Gilbert GL, Marks GB. Recurrence of tuberculosis in a low-incidence setting. Eur Respir J. 2009;33(1):160–7.CrossRefPubMed
27.
go back to reference Nunn AJ, Phillips PP, Mitchison DA. Timing of relapse in short-course chemotherapy trials for tuberculosis. Int J Tuberc Lung Dis. 2010;14(2):241–2.PubMed Nunn AJ, Phillips PP, Mitchison DA. Timing of relapse in short-course chemotherapy trials for tuberculosis. Int J Tuberc Lung Dis. 2010;14(2):241–2.PubMed
28.
go back to reference Pareek M, Evans J, Innes J, Smith G, Hingley-Wilson S, Lougheed KE, Sridhar S, Dedicoat M, Hawkey P, Lalvani A. Ethnicity and mycobacterial lineage as determinants of tuberculosis disease phenotype. Thorax. 2013;68(3):221–9.CrossRefPubMed Pareek M, Evans J, Innes J, Smith G, Hingley-Wilson S, Lougheed KE, Sridhar S, Dedicoat M, Hawkey P, Lalvani A. Ethnicity and mycobacterial lineage as determinants of tuberculosis disease phenotype. Thorax. 2013;68(3):221–9.CrossRefPubMed
29.
go back to reference Kruijshaar ME, Abubakar I. Increase in extrapulmonary tuberculosis in England and Wales 1999–2006. Thorax. 2009;64(12):1090–5.CrossRefPubMed Kruijshaar ME, Abubakar I. Increase in extrapulmonary tuberculosis in England and Wales 1999–2006. Thorax. 2009;64(12):1090–5.CrossRefPubMed
30.
go back to reference Tuberculosis in England: 2015 report. London: Public Health England. p. 2015. Tuberculosis in England: 2015 report. London: Public Health England. p. 2015.
31.
go back to reference Global Tuberculosis Report. In. Geneva: World Health Organization 2015. Global Tuberculosis Report. In. Geneva: World Health Organization 2015.
32.
go back to reference Awofeso N. Anti-tuberculosis medication side-effects constitute major factor for poor adherence to tuberculosis treatment. Bull World Health Organ. 2008;86(3):B–d.CrossRefPubMedPubMedCentral Awofeso N. Anti-tuberculosis medication side-effects constitute major factor for poor adherence to tuberculosis treatment. Bull World Health Organ. 2008;86(3):B–d.CrossRefPubMedPubMedCentral
33.
go back to reference Shin SS, Pasechnikov AD, Gelmanova IY, Peremitin GG, Strelis AK, Mishustin S, Barnashov A, Karpeichik Y, Andreev YG, Golubchikova VT, et al. Adverse reactions among patients being treated for MDR-TB in Tomsk, Russia. Int J Tuberc Lung Dis. 2007;11(12):1314–20.PubMed Shin SS, Pasechnikov AD, Gelmanova IY, Peremitin GG, Strelis AK, Mishustin S, Barnashov A, Karpeichik Y, Andreev YG, Golubchikova VT, et al. Adverse reactions among patients being treated for MDR-TB in Tomsk, Russia. Int J Tuberc Lung Dis. 2007;11(12):1314–20.PubMed
34.
go back to reference Leung CC, Yew WW, Chan CK, Chang KC, Law WS, Lee SN, Tai LB, Leung EC, Au RK, Huang SS, et al. Smoking adversely affects treatment response, outcome and relapse in tuberculosis. Eur Respir J. 2015;45(3):738–45.CrossRefPubMed Leung CC, Yew WW, Chan CK, Chang KC, Law WS, Lee SN, Tai LB, Leung EC, Au RK, Huang SS, et al. Smoking adversely affects treatment response, outcome and relapse in tuberculosis. Eur Respir J. 2015;45(3):738–45.CrossRefPubMed
35.
go back to reference O'Leary SM, Coleman MM, Chew WM, Morrow C, McLaughlin AM, Gleeson LE, O'Sullivan MP, Keane J. Cigarette smoking impairs human pulmonary immunity to mycobacterium tuberculosis. Am J Respir Crit Care Med. 2014;190(12):1430–6.CrossRefPubMed O'Leary SM, Coleman MM, Chew WM, Morrow C, McLaughlin AM, Gleeson LE, O'Sullivan MP, Keane J. Cigarette smoking impairs human pulmonary immunity to mycobacterium tuberculosis. Am J Respir Crit Care Med. 2014;190(12):1430–6.CrossRefPubMed
37.
go back to reference Bryant JM, Harris SR, Parkhill J, Dawson R, Diacon AH, van Helden P, Pym A, Mahayiddin AA, Chuchottaworn C, Sanne IM, et al. Whole-genome sequencing to establish relapse or re-infection with mycobacterium tuberculosis: a retrospective observational study. Lancet Respir Med. 2013;1(10):786–92.CrossRefPubMedPubMedCentral Bryant JM, Harris SR, Parkhill J, Dawson R, Diacon AH, van Helden P, Pym A, Mahayiddin AA, Chuchottaworn C, Sanne IM, et al. Whole-genome sequencing to establish relapse or re-infection with mycobacterium tuberculosis: a retrospective observational study. Lancet Respir Med. 2013;1(10):786–92.CrossRefPubMedPubMedCentral
Metadata
Title
A nested case–control study of predictors for tuberculosis recurrence in a large UK Centre
Authors
Andrew Rosser
Matthew Richardson
Martin J. Wiselka
Robert C. Free
Gerrit Woltmann
Galina V. Mukamolova
Manish Pareek
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2018
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-017-2933-4

Other articles of this Issue 1/2018

BMC Infectious Diseases 1/2018 Go to the issue